Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ginseng - Nutraceuticals World

What are you searching for?

Sign in
Research

Ginseng

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Indication: Fatigue (due to cancer)


Source: 43rd Annual Meeting of the American Society of Clinical Oncology, Chicago, IL (June)

Research: In a pilot study of 282 patients, researchers randomly assigned them to take either a placebo or one of three daily doses of ginseng: 750 mg, 1000 mg or 2000 mg. The product used in the study was 4-year-old American ginseng root, which was assayed by an independent company. The study tested the three doses of ginseng in patients with a variety of cancers and a life-expectancy of at least 6 months. About half of the patients were receiving chemotherapy.

Results: After 8 weeks, responses on the Brief Fatigue Inventory (BFI) and on the vitality subscale of the SF-36 quality-of-life questionnaire showed an improvement over placebo for the two higher doses of ginseng. In addition, 25% of patients taking 1000 mg of ginseng and 27% of patients taking 2000 mg reported feeling “moderately better” or “much better,” compared with only 10% of patients in both the placebo and the 750 mg ginseng groups.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters